Comment: Barbiturates may improve adverse results, which includes respiratory despair, produced by toxic doses of TCAs. With therapeutic doses of TCAs, barbiturates increase metabolism and decrease blood concentrations of TCAs.Steer clear of; coadministration with CYP3A inducers might result in decreased plasma concentrations of elvitegravir and/or